At present, the injection pen is mainly used for subcutaneous injection of various biological drugs, such as recombinant human growth hormone (drugs for dwarfism), insulin and analogs (drugs for diabetes), GLP-1 drugs (drugs for diabetes), teriparatide (osteoporosis drugs), recombinant human follicle-stimulating hormone (drugs for infertility), apomorphine (drugs for Parkinson's disease) and other chronic disease drugs that require medium- and long-term self-medication, as well as high-priced targeted drugs such as adalimumab and alirocumab, and consumer markets such as high-end beauty needles
Unlike other weight-loss injections, Retatrutide is a triple hormone receptor agonist, meaning it acts on three key receptors in hunger and metabolic regulation
Furthermore, it enhances spatial memory by promoting neurogenesis and increasing levels of brain-derived neurotrophic factor (BDNF) in the hippocampus, the brains primary memory centre (Er et al
Single nuclei transcriptomics delineates complex immune and kidney cell interactions contributing to kidney allograft fibrosis
ZeroHarm's Approach: Companies like ZeroHarm Sciences focus on enhancing bioavailability